Members of UIPL and producers of innovative medicines, in line with the Code of Conduct, are committed to the Public Disclosure of Transfers of Value to healthcare organizations and professionals in Bosnia and Herzegovina.

The primary objective of this disclosure is to ensure greater transparency in the relationships between the pharmaceutical industry and healthcare professionals and institutions. This contributes to maintaining and strengthening trust between doctors and pharmaceutical companies, while also enhancing the reputation of both the pharmaceutical sector and the medical community.

By clicking on a company logo or the link below, you will be redirected to the Transfer of Value Disclosure section, which each UIPL member is required to publish on their official website.